CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Open-market buy Director bought 45,000 shares at $5.64 ($253,868)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award EVP, CHIEF FINANCIAL OFFICER acquired 61,266 shares (grant or award)
- 4 Grant or award EVP, CHIEF SCIENTIFIC OFFICER acquired 39,855 shares (grant or award)
- 4 Planned sale CEO sold 77,824 shares at $9.42 ($732,884)
- 4 Planned sale SVP, CHIEF MEDICAL OFFICER sold 20,327 shares at $9.42 ($191,425)
- 144 Insider Sale of Securities
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
Page 9 of 37 · 731 filings